News

Sana Biotechnology, Inc. (NASDAQ:SANA) ranks among the best CRISPR stocks to buy. On June 24, Citizens JMP reaffirmed its $5 ...
For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...
Below are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal ...
SAN DIEGO, June 18, 2025--DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85th ...
UAB Comprehensive Diabetes Center (UCDC) scientist Kirk Habegger, Ph.D., is featured in the Diabetes Spotlight in the May 2025 issue of Diabetes, the flagship research publication of the American ...
ABSTRACT The diagnostic criteria for gestational diabetes mellitus (GDM), a transient hyperglycemic state during pregnancy, has varied remarkably over time, resulting in a diversity of prevalence ...
Diabetes directly led to 1.6 million deaths in 2021, with nearly half of them occurring before 70 years of age, WHO stated. Another 530,000 related deaths were attributed to kidney disease.
For example, research shows that diabetes-specific nutrition formulas can support glycemic management. Through the collaboration, the ADA will review and consolidate the latest evidence to help ...
The American Diabetes Association® (ADA) and Abbott recently announced a collaboration to better understand the nutritional needs of people living with diabetes, obesity, and metabolic ...
Here's a scary stat: More than 30 million people in the U.S. have diabetes, according to the Centers for Disease Control and Prevention (CDC)—and 25 percent don't even know they have it. But it ...
New data focused on advanced technology innovations for managing type 2 diabetes (T2D) highlight the positive impact of automated insulin delivery systems (AID) and continuous glucose monitoring ...
The direct medical costs associated with diabetes increased by 7% from $287.0 billion in 2017 to $306.6 billion in 2022. The total annual cost of diabetes in 2022 was reported to be $412.9 billion ...